Correlation Between Magenta Therapeutics and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and Protara Therapeutics, you can compare the effects of market volatilities on Magenta Therapeutics and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and Protara Therapeutics.
Diversification Opportunities for Magenta Therapeutics and Protara Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Magenta and Protara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Magenta Therapeutics and Protara Therapeutics
Given the investment horizon of 90 days Magenta Therapeutics is expected to generate 2.89 times less return on investment than Protara Therapeutics. In addition to that, Magenta Therapeutics is 1.53 times more volatile than Protara Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 335.00 in Protara Therapeutics on August 29, 2024 and sell it today you would lose (41.00) from holding Protara Therapeutics or give up 12.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.45% |
| Values | Daily Returns |
Magenta Therapeutics vs. Protara Therapeutics
Performance |
| Timeline |
| Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Protara Therapeutics |
Magenta Therapeutics and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Magenta Therapeutics and Protara Therapeutics
The main advantage of trading using opposite Magenta Therapeutics and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |